Search Login Register

Dyshidrotic Eczema (Pompholyx) Summary

Description: A recurrent eczematous reaction characterized by the development of vesicular eruptions on the palms and soles, particularly along the sides and between the digits. It is accompanied by pruritus, a burning sensation, and hyperhidrosis. The disease is self-limiting, lasting only a few weeks. (Dorland, 27th ed)

Also Known As: Pompholyx; Eczema, Dyshidrotic; Eczema, Dyshydrotic; Dyshidrotic Eczemas; Dyshydrotic Eczema Show All >>

Networked: 65 relevant articles (5 outcomes, 5 trials/studies) for this Disease

Key Drugs and Agents for Dyshidrotic Eczema

Efficacy Chart >>
Drugs and Important Biological Agents (IBA) related to treatments:
  1. Azathioprine (Imuran) : 1 outcome 1 study in 2 results : FDA 7 Generic
  2. Intravenous Immunoglobulins (IVIG) : 1 outcome in 5 results : FDA 1
  3. Immunoglobulins (Immunoglobulin) : 1 outcome in 5 results : IBA
  4. Adrenal Cortex Hormones (Corticosteroids) : 1 outcome in 5 results : IBA
  5. Botulinum Toxins (Botulinum Toxin) : 1 outcome in 2 results : IBA
  6. Calcineurin : 1 outcome in 1 result : IBA
  7. Nickel : 2 studies in 20 results : IBA
  8. Cobalt : 1 study in 4 results : IBA
  9. Proteins (Proteins, Gene) : 1 study in 2 results : IBA
  10. Peruvian balsam (balsam of Peru) : 1 study in 2 results : IBA
Show All >>

Diseases Related to Dyshidrotic Eczema

  1. Psoriasis (Pustulosis Palmaris et Plantaris)
  2. Atopic Dermatitis (Atopic Eczema)
  3. Photosensitivity Disorders (Photodermatitis)
  4. Muscle Weakness
  5. Hypersensitivity (Allergy)
Show All >>

Key Therapies for Dyshidrotic Eczema

Efficacy Chart >>
  1. Phototherapy (Light Therapy) : 1 outcome 1 study in 2 results
  2. Psychology Biofeedback (Biofeedback) : 2 results
  3. Aftercare (After-Treatment) : 2 results
  4. Sympathectomy (Sympathectomies) : 1 result
  5. PUVA Therapy : 1 result
Show All >>

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.